Accelerating the path to a non-opioid future.
Committed to finding new, safe ways to alleviate human suffering responsibly.
For too long, the options for those in chronic and acute pain have been too limited.
Today, CerSci is poised to deliver a new generation of non-opioid medicines to treat acute post-operative and chronic neuropathic pain.
A new approach to developing novel pain therapeutics.
Rather than concentrating on ion channel and GPCR targets, CerSci's science is focused on interrupting pathways that cause pain. This mandate sets CerSci apart from other more common approaches to treating pain.
Prevention / Alleviation
of tractile allodynia, thermal hyperalgesia, and mechanical hypersensitivity
Sustained relief
Single dose can last for days
Lack of tolerance
Across all species so far
No GI ulceration
or genotoxicity signals
No sedation
or motor impairment side effects
No tolerance
No effects on core body temperature
CT-044, a powerful reactive species decomposition accelerant.
Learn more about the science behind Cersci’s lead molecular asset here.
A mission equal parts scientific and humanitarian.
Cersci was founded to deliver much needed new medicines through understanding the underlying mechanisms behind pain, and conquering the core problem of neuronal sensitization.